| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jun 03, 2024 |
CHIEF OPERATING OFFICER
Trans History: 22
|
CHIEF OPERATING OFFICER | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 75,000 | -- | 75,000 |
| Mar 05, 2024 |
Director, PRESIDENT AND CEO
Trans History: 32
|
Director, PRESIDENT AND CEO | Form 4 | Other acquisition or disposition | -- | -- | 502 |
| Feb 15, 2024 |
CHIEF MEDICAL OFFICER
Trans History: 15
|
CHIEF MEDICAL OFFICER | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,081 | $1.27 | 31,487 |
| Feb 15, 2024 |
GENERAL COUNSEL
Trans History: 6
|
GENERAL COUNSEL | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 402 | $1.27 | 3,525 |
| Feb 15, 2024 |
Director, PRESIDENT AND CEO
Trans History: 32
|
Director, PRESIDENT AND CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 3,073 | $1.27 | 77,663 |
| Feb 15, 2024 |
CHIEF OPERATING OFFICER
Trans History: 22
|
CHIEF OPERATING OFFICER | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,229 | $1.27 | 48,644 |
| Sep 20, 2023 |
Chief Financial Officer
Trans History: 4
|
Chief Financial Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Sep 18, 2023 |
Chief Medical Officer
Trans History: 15
|
Chief Medical Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- | 144,794 |
| Sep 18, 2023 |
Chief Medical Officer
Trans History: 15
|
Chief Medical Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,000 | -- | 40,000 |
| Sep 18, 2023 |
Chief Financial Officer
Trans History: 4
|
Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 106,000 | -- | 106,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.